Managing Rising Medication Cost

Dec 8, 2016
In a recent presentation, Dr. Steve Miller joined pharmaceutical executives and other health care leaders to discuss the evolving role of PBMs.
Tags
  • Cancer
  • Hepatitis C
  • High Blood Cholesterol
  • Inflammatory Conditions

ES Bottles

Pharmaceutical companies, benefit providers, policymakers and pharmaceutical benefit providers all have a role to play in keeping medicine within reach of patients.

It’s crucial to work together to build a sustainable system where patients and payers can afford to buy the innovative, often life-saving treatments being developed by pharma companies.

Addressing Payers Biggest Challenges

Over the past two years, Express Scripts has built industry-leading solutions to ensure patients get the best care, while controlling costs. Under our SafeGuardRxSM umbrella, we are addressing the leading drivers of drug trend including cancer and inflammatory conditions.

In a recent presentation at the Pharmaceutical Executive Summit, Dr. Steve Miller offered an overview of these solutions, and suggestions to kick off a discussion on how pharmaceutical companies, payers and the federal government can keep medicine accessible and affordable for every American.

Click here to download the presentation.

Author Bio

Lab Staff
comments powered by Disqus